No claims made in this content have been evaluated by the Food and Drug Administration
Its active ingredient, Semaglutide base (0.25 mg), is an FDA-approved glucagon-like peptide-1 (GLP-1) receptor agonist
Seccombe D et al
Serving Oak Brook and the greater Chicago area, we specialize in both surgical and non-surgical treatments, including innovative IV therapy options
This medication works by stimulating insulin secretion, promoting satiety (feeling of fullness), suppressing glucagon secretion, and delaying gastric emptying
Although current kidney organoids can replicate certain renal functions, they still lag behind native kidneys in terms of cell type diversity, tissue architecture, and functional complexity, which limits their therapeutic efficacy in renal diseases (64)